Highlights and recent developments in allergic diseases in EAACI journals (2019)

Area of Science:

• Allergy and Clinical Immunology
• Respiratory Medicine
• Translational Science

Background:

• The European Academy of Allergy and Clinical Immunology (EAACI) promotes allergy prevention and knowledge dissemination.
• EAACI publishes in three leading journals: Allergy, Pediatric Allergy and Immunology, and Clinical and Translational Allergy.
• Disseminating knowledge to stakeholders, including junior members, is a core EAACI objective.

Purpose of the Study:

• To highlight key advancements in allergy and respiratory disease research and clinical translation in 2019.
• To showcase progress in understanding disease mechanisms and developing new therapeutic strategies.
• To emphasize the importance of prevention and early detection in managing allergic conditions.

Main Methods:

• Review of scientific literature and clinical studies published in 2019.
• Analysis of progress in basic science, biomarker development, and clinical trials.
• Synthesis of findings related to disease mechanisms, prevention, and treatment.

Main Results:

• Substantial progress in identifying molecular and cellular mechanisms of allergic and respiratory diseases.
• Development of biomarkers for disease prediction and novel prevention/intervention studies.
• Advancements in understanding multimorbidities, new drug introductions, and numerous allergen immunotherapy studies.

Conclusions:

• 2019 marked significant progress in translating basic science discoveries into clinical applications for allergy and respiratory diseases.
• Enhanced understanding of disease mechanisms, biomarkers, and immunotherapies are paving the way for improved patient outcomes.
• Continued research and dissemination of knowledge are crucial for effective allergy and asthma prevention and management.